ArticleCurrent cancer drug targets2009

Ribonucleotide reductase as one important target of [Tris(1,10-phenanthroline)lanthanum(III)] trithiocyanate (KP772).

P Heffeter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.